Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study

被引:21
作者
Tin, Adrienne [1 ]
Grams, Morgan E. [2 ]
Maruthur, Nisa M. [3 ]
Astor, Brad C. [4 ,5 ]
Couper, David [6 ]
Mosley, Thomas H. [7 ]
Fornage, Myriam [8 ]
Parekh, Rulan S. [9 ]
Coresh, Josef [1 ]
Kao, Wen Hong Linda [1 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Div Gen Internal Med, Baltimore, MD USA
[4] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA
[5] Univ Wisconsin, Dept Med, Dept Populat Hlth Sci, Madison, WI USA
[6] Univ N Carolina, Dept Biostat, Collaborat Studies Coordinating Ctr, Chapel Hill, NC USA
[7] Univ Mississippi, Med Ctr, Div Geriatr, Jackson, MS 39216 USA
[8] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA
[9] Hosp Sick Children, Div Nephrol, Toronto, ON M5G 1X8, Canada
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2015年 / 10卷 / 05期
基金
美国国家卫生研究院;
关键词
CHRONIC KIDNEY-DISEASE; PROTEIN-C; ARIC HEMOSTASIS; HEART-DISEASE; FACTOR-VIII; PLASMA; INFLAMMATION; PROGRESSION; ACTIVATION; MARKERS;
D O I
10.2215/CJN.08340814
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background and objectives Hemostatic factors have been associated with kidney function decline, and evidence suggests stronger effects among African Americans. The presence of APOL1 renal risk variants, common in African Americans, might partly underlie this risk difference. Design, setting, participants, & measurements A total of 13,337 participants in the Atherosclerosis Risk in Communities study were followed from 1987-1989 until 2010. Participants were categorized into three groups by ancestry and APOL1 risk status: European Americans (n=10,206), African Americans with zero or one APOL1 risk allele (n=2,733), and African Americans with two APOL1 risk alleles (n=398). ESRD events were ascertained through linkage to the US Renal Data System. Cox regression was used to estimate the risk for ESRD associated with hemostatic factors (factor VIIc, factor VIIIc, fibrinogen, von Willebrand factor, protein C, and antithrombin III). Results There were 232 cases of ESRD over 21.5 years (European Americans, 119; African Americans with zero or one APOL1 risk allele, 94; African Americans with two APOL1 risk alleles, 19). In unadjusted and adjusted analysis of the overall population, higher levels of all hemostatic factors, except antithrombin III, were significantly associated with ESRD (all P<0.05). Factor VIIc had the strongest association (per one interquartile range; adjusted hazard ratio, 1.46; 95% confidence interval, 1.21 to 1.76). With the exception of fibrinogen, the risk associated with each hemostatic factor was stronger in African Americans with two APOL1 risk alleles compared with the other two groups. Statistically significant interactions were seen for factor VIIIc and protein C (interaction between those with two APOL1 risk allele and the other two groups: P<0.02 for factor VIIIc and <0.04 for protein C). Conclusions Higher levels of factor VIIc, VIIIc, fibrinogen, von Willebrand factor, and protein C were associated with ESRD risk, with a significantly stronger association of factor VIIIc and protein C in African Americans with two APOL1 risk alleles.
引用
收藏
页码:784 / 790
页数:7
相关论文
共 44 条
[1]   Hemostatic markers are associated with the risk and prognosis of atrial fibrillation: The ARIC study [J].
Alonso, Alvaro ;
Tang, Weihong ;
Agarwal, Sunil K. ;
Soliman, Elsayed Z. ;
Chamberlain, Alanna M. ;
Folsom, Aaron R. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 155 (02) :217-222
[2]   Inflammation, Hemostasis, and the Risk of Kidney Function Decline in the Atherosclerosis Risk in Communities (ARIC) Study [J].
Bash, Lori D. ;
Erlinger, Thomas P. ;
Coresh, Josef ;
Marsh-Manzi, Jane ;
Folsom, Aaron R. ;
Astor, Brad C. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) :596-605
[3]   Plasma Apolipoprotein L1 Levels Do Not Correlate with CKD [J].
Bruggeman, Leslie A. ;
O'Toole, John F. ;
Ross, Michael D. ;
Madhavan, Sethu M. ;
Smurzynski, Marlene ;
Wu, Kunling ;
Bosch, Ronald J. ;
Gupta, Samir ;
Pollak, Martin R. ;
Sedor, John R. ;
Kalayjian, Robert C. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 25 (03) :634-644
[4]  
Chambless L E, 1992, Ann Epidemiol, V2, P723
[5]   The interactions between inflammation and coagulation [J].
Esmon, CT .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 131 (04) :417-430
[6]   The Association Between APOL1 Risk Alleles and Longitudinal Kidney Function Differs by HIV Viral Suppression Status [J].
Estrella, Michelle M. ;
Li, Man ;
Tin, Adrienne ;
Abraham, Alison G. ;
Shlipak, Michael G. ;
Penugonda, Sudhir ;
Hussain, Shehnaz K. ;
Palella, Frank J., Jr. ;
Wolinsky, Steven M. ;
Martinson, Jeremy J. ;
Parekh, Rulan S. ;
Kao, W. H. Linda .
CLINICAL INFECTIOUS DISEASES, 2015, 60 (04) :646-652
[7]   Activation of factor VIII and mechanisms of cofactor action [J].
Fay, PJ .
BLOOD REVIEWS, 2004, 18 (01) :1-15
[8]   Low protein C and incidence of ischemic stroke and coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study [J].
Folsom, A. R. ;
Ohira, T. ;
Yamagishi, K. ;
Cushman, M. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (11) :1774-1778
[9]   Protein C, antithrombin, and venous thromboembolism incidence - A prospective population-based study [J].
Folsom, AR ;
Aleksic, N ;
Wang, L ;
Cushman, M ;
Wu, KK ;
White, RH .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (06) :1018-1022
[10]   APOL1 Variants Associate with Increased Risk of CKD among African Americans [J].
Foster, Meredith C. ;
Coresh, Josef ;
Fornage, Myriam ;
Astor, Brad C. ;
Grams, Morgan ;
Franceschini, Nora ;
Boerwinkle, Eric ;
Parekh, Rulan S. ;
Kao, W. H. Linda .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (09) :1484-1491